Conference Coverage
Conference Coverage
Robust immune response after COVID-19 boosters in those with IBD
Data support an additional vaccine dose of mRNA vaccine in patients at risk for an inadequate response to the initial series, says expert.
Conference Coverage
IBD-VTE score serves as reminder to assess postdischarge risk
The new score is based on data from a large number of patients and uses eight readily available patient factors.
Conference Coverage
LUCENT-1: Mirikizumab sees phase 3 success in UC treatment
Mirikizumab targets a subunit of interleukin 23, which has shown promise in other conditions.
Conference Coverage
‘Superdonor’ samples don’t increase FMT success in ulcerative colitis
RESTORE-UC trial results contradict positive results seen in previous trials despite using highly standardized, “superdonor” samples.
Conference Coverage
Meta-analysis favors SubQ infliximab biosimilar over vedolizumab in Crohn’s disease
Researchers evaluated results of seven major studies to compare efficacy and safety of the two agents in Crohn’s disease and ulcerative colitis....
Conference Coverage
Two factors linked to higher risk of long COVID in IBD
Conference Coverage
Handle with care: Managing IBD in older patients
Patients 60 and older with chronic or newly diagnosed IBD may have comorbidities or use medications that can interfere with IBD therapies.
Conference Coverage
Malnutrition common in patients with IBD
As many as 85% of patients hospitalized with IBD may be malnourished, dietary experts cautioned.
Conference Coverage
Breakthrough COVID-19 milder in vaccinated patients with IBD
Patients with inflammatory bowel disease who are vaccinated but still develop COVID experience milder disease than those who are unvaccinated.
Conference Coverage
Anesthesia care team may be quicker for GI endoscopy
New data show the efficiency gains of monitored anesthesia care over nurse-administered sedation, but both approaches have pros and cons.